Stocks
Intellia Therapeutics (NTLA) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -261.0 | -450.6 | -506.3 | -524.0 | -396.8 | -397.6 | ||
| Changes by years, y/y, % | +100% | +73% | +12% | +3% | -24% | +25.0% | |||
Intellia Therapeutics. EBITDA US GAAP, bln rub
Intellia Therapeutics. EBITDA US GAAP, changes, %
Intellia Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Intellia Therapeutics (NTLA) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -118.3 | -98.8 | -96.4 | -95.4 | -94.0 | -397.6 | |
| Changes by years, y/y, % | +6% | -28% | -32% | -29% | -21% | |||
| Changes by quarters, q/q, % | -12% | -17% | -2% | -1% | -1% | |||
